|
Mr. Southwell has been Executive Vice President and Chief Financial Officer of Sepracor since June 1994. During this time, Sepracor and its subsidiaries have raised approximately $3.0 billion in three equity, and nine convertible financings. Of these twelve transactions, three were public offerings, and nine were private placements of convertible securities. More recently, Sepracor repurchased or exchanged approximately $1.3 billion of convertible bonds. During his tenure, Sepracor's market capitalization has risen from $70 million to approximately $6 billion. In May 2007, Mr. Southwell assumed the additional responsibility of leadership of corporate planning, development, and licensing.
Prior to joining Sepracor, Mr. Southwell was a Vice President in investment banking with Lehman Brothers in New York. His career at Lehman spanned ten years, and included mergers, acquisitions, leveraged buyouts, restructurings and debt and equity financing transactions. While at Lehman, he managed the IPO of Sepracor in September 1991.
Mr. Southwell holds an MBA from the Tuck School at Dartmouth College, and a BA from Rice University in Houston, Texas. Mr. Southwell serves on the board of BioSphere Medical, the MBA Advisory Board of the Tuck School, and the board of PTC Therapeutics. | 